Skip to main content

Investor Relations

Latest News

View All News

Latest Quarterly Information

View All Financial Reports

Recent Presentations

Find Out More

Shareholder Meetings

Learn More about: Shareholder Meetings

Summit Presentations

Learn More about: Summit Presentations

Corporate Governance

Learn More about: Corporate Governance
Sign Up for Updates

For further information on how we protect your information, please refer to our Privacy Policy.

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

© Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).